Current status of stem cell-derived therapies for Parkinson’s disease : from cell assessment and imaging modalities to clinical trials
Curative therapies or treatments reversing the progression of Parkinson’s disease (PD) have attracted considerable interest in the last few decades. PD is characterized by the gradual loss of dopaminergic (DA) neurons and decreased striatal dopamine levels. Current challenges include optimizing neur...
Main Authors: | Jang, Se Eun, Qiu, Lifeng, Chan, Ling Ling, Tan, Eng-King, Zeng, Li |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/145662 |
Similar Items
-
Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish
by: Lisa M. Barnhill, et al.
Published: (2020-07-01) -
Excessive Daytime Sleepiness in Parkinson’s Disease
by: Liu H, et al.
Published: (2022-09-01) -
Animal Models of Autosomal Recessive Parkinsonism
by: Guendalina Bastioli, et al.
Published: (2021-07-01) -
A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
by: Giselle Prunell, et al.
Published: (2022-11-01) -
Intravenous Transplantation of Adipose-Derived Mesenchymal Stem Cells Promoted The Production of Dopaminergic Neurons and Improved Spatial Memory in A Rat Model of Parkinson’s Disease
by: Helia Hamedi, et al.
Published: (2023-05-01)